@article{article, title  = {{A phase 2 randomized, double-blind, placebo-controlled trial of endocrine therapy ± radium-223 dichloride (Ra-223) in HER2- hormone receptor+ breast cancer patients with bone metastases.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2016}},

 month = {{5}},

 author = {{Coleman RE and Li R and Sawhney AG and Petrenciuc O and Rugo HS}},

 doi = {{10.1200/jco.2016.34.15_suppl.tps622}},

 volume = {{34}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{TPS622-TPS622}},

 note = {{Accessed on 2025/10/10}}}